Moreover, in mouse models of prostate cancer, the reduction of DCX + neural progenitors in the sub-ventricular zone was associated with disruption of the blood–brain barrier and the entry into the circulation of DCX + cells that infiltrate the tumor and generate new adrenergic neurons (Mauffrey et al., 2019). This evidence concerns the gene DCX and prostate carcinoma.